2015
What is the role of dosimetry in patients with advanced thyroid cancer?
Chen MK, Cheng DW. What is the role of dosimetry in patients with advanced thyroid cancer? Current Opinion In Oncology 2015, 27: 33-37. PMID: 25319079, DOI: 10.1097/cco.0000000000000145.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsPositron emission tomography-computed tomographyThyroid cancerLesional dosimetryPretreatment dosimetryAdvanced differentiated thyroid cancerEmission tomography-computed tomographyIntermediate-risk patientsAdvanced thyroid cancerMetastatic thyroid cancerDifferentiated thyroid cancerTomography-computed tomographyRenal insufficiencyElderly patientsRenal failureRisk patientsProlonged withdrawalPatientsHigh dosesThyroid hormonesSimilar outcomesTreatment dosageCancerRole of dosimetryUptake of iodineWhole body
2012
The Utility of I-123 Pretherapy Scan in I-131 Radioiodine Therapy for Thyroid Cancer
Chen MK, Yasrebi M, Samii J, Staib LH, Doddamane I, Cheng DW. The Utility of I-123 Pretherapy Scan in I-131 Radioiodine Therapy for Thyroid Cancer. Thyroid 2012, 22: 304-309. PMID: 22300251, DOI: 10.1089/thy.2011.0203.Peer-Reviewed Original ResearchMeSH KeywordsAdenocarcinoma, PapillaryAdenoma, OxyphilicAdolescentAdultAgedAged, 80 and overCarcinomaCarcinoma, PapillaryFemaleHumansIodine RadioisotopesMaleMiddle AgedNeoplasm MetastasisRadionuclide ImagingRadiopharmaceuticalsRetrospective StudiesThyroid Cancer, PapillaryThyroid NeoplasmsThyroidectomyConceptsPretherapy scansThyroid remnantsLymph nodesDistant metastasisYale-New Haven HospitalLarge thyroid remnantsCervical lymph nodesTime of thyroidectomyAdditional clinical informationNew Haven HospitalNeck uptakeRadioiodine therapyWhole-body imagesEuthyroid statePathology reportsThyroid cancerTreatment protocolLocal lymphClinical informationThyroidectomy specimensPretherapyConfidence intervalsScansThyroidectomyMetastasis
2010
Recombinant human thyroid-stimulating hormone as an alternative for thyroid hormone withdrawal in thyroid cancer management
Chen MK, Doddamane I, Cheng DW. Recombinant human thyroid-stimulating hormone as an alternative for thyroid hormone withdrawal in thyroid cancer management. Current Opinion In Oncology 2010, 22: 6-10. PMID: 19844179, DOI: 10.1097/cco.0b013e3283339d5d.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsRecombinant human thyroid-stimulating hormoneHuman thyroid-stimulating hormoneMetastatic thyroid cancerThyroid-stimulating hormoneThyroid cancerThyroglobulin levelsWhole body radiation exposureThyroid hormone withdrawalThyroid remnant ablationFurther prospective studiesLong-term outcomesRate of recurrenceSurveillance of patientsThyroid cancer managementBody radiation exposureNegative predictive valueRadioiodine ablationPersistent diseaseRadioiodine treatmentRemnant ablationThyroid remnantsWithdrawal patientsPatients' qualityPatient groupProspective study